Urological Associates of Lancaster is a clinical research site located in Lancaster, Pennsylvania, United States 17604-3200.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Urological Associates of Lancaster has participated in 14 clinical trials.
Therapeutic areas: Prostate Cancer, Bladder Cancer, Metastatic Prostate Cancer.
Sponsors: PRAECIS Pharmaceuticals Inc., Spectrum Pharmaceuticals, Inc, Christopher Sweeney, MBBS.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Urological Associates of Lancaster has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Urological Associates of Lancaster has 14 clinical trials on record. Their work covers Prostate Cancer, Bladder Cancer, Metastatic Prostate Cancer.
Yes — Urological Associates of Lancaster holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.